Yes, repeat the microalbumin test now.
You should repeat the urine microalbumin test at this 3-month mark, as your value of 406 mg/g indicates macroalbuminuria (>300 mg/g), which requires more frequent monitoring than the standard annual screening. 1
Why Repeat Testing is Critical at This Level
Your albumin-to-creatinine ratio of 406 mg/g places you in the macroalbuminuria category (also called severely increased albuminuria), which is defined as >300 mg/g creatinine 1. This is not microalbuminuria (30-299 mg/g)—it represents more advanced kidney damage that signals:
- Higher risk for progression to end-stage renal disease 2
- Significantly elevated cardiovascular disease risk 2
- Need for aggressive treatment monitoring 1
Monitoring Frequency Guidelines
The National Kidney Foundation and American Diabetes Association guidelines are clear about monitoring frequency based on albuminuria severity:
For patients with documented albuminuria who are undergoing treatment:
- Retest within 6 months to determine if treatment goals and reduction in albuminuria have been achieved 1
- If eGFR is <60 mL/min/1.73 m² and/or albuminuria is >30 mg/g, repeat uACR every 6 months 3
After the initial 6-month assessment:
- If treatment results in significant reduction: annual testing 1
- If no reduction occurs: evaluate blood pressure control, ensure renin-angiotensin-aldosterone system inhibitors (ACE inhibitors or ARBs) are part of therapy, and modify treatment accordingly 1
Important Considerations for Your Test
When you repeat the test, ensure:
- Avoid vigorous exercise for 24 hours before sample collection 1
- Use a first-morning spot urine sample for the albumin-to-creatinine ratio 1, 2
- Rule out confounding factors: infection, fever, marked hyperglycemia, marked hypertension, or congestive heart failure can falsely elevate results 2
Treatment Implications
At your level of albuminuria (>300 mg/g), you should be on:
- ACE inhibitor or ARB therapy (proven to delay progression of nephropathy) 2, 4, 5
- Blood pressure target <130/80 mmHg 2, 5
- Optimal glucose control if diabetic 2, 4, 2
The repeat test at 3 months will help assess whether your current treatment regimen is effectively reducing albuminuria—a >30% sustained reduction is considered clinically meaningful and indicates slowed progression of kidney disease 3.
Common Pitfalls to Avoid
- Don't wait for annual screening when you have macroalbuminuria—this level requires 6-month monitoring 1, 3
- Don't assume one elevated value is sufficient—while your 406 mg/g is clearly abnormal, tracking the trend is essential for treatment decisions 3
- Be aware that day-to-day variability exists: at your level of albuminuria, a change of approximately ±83% may represent biological variation rather than true disease change 6